Sudeep Pharma’s upcoming IPO has drawn strong early interest among institutions as investors track the company’s specialty chemicals portfolio and export footprint. Market participants expect notable demand from domestic funds due to sectoral tailwinds and steady financial performance. The issue includes both fresh capital and an offer for sale.